In a multi-ethnic population-based study, we investigate the change in indicators of adiposity (being weight gain and gain of total fat, truncal fat and mean skinfold thickness) from early pregnancy to 28 weeks of gestation overall and across ethnic groups, and explore the association between the change in indicators of adiposity and gestational diabetes (GDM). DESIGN: Weight, skinfold thickness and bioelectrical impedance analysis were performed twice in 728 pregnant women in gestational week 15 (visit 1) and week 28 (visit 2). GDM was defined by the modified International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria (1-hour glucose not available). RESULTS: An increase in all indicators of adiposity gave increased odds ratios (OR) for GDM. After adjusting for pre-pregnant body mass index, a 0.14 kg per week (one standard deviation (s.d.)) increase in truncal fat gave an OR of 1.31 (95% CI 1.10-1.56), while a 0.21 kg per week (one s.d.) weight gain gave an OR of 1.23 (95% CI 1.04-1.46) for GDM. The ORs for the indicators of adiposity remained after additional adjustments for insulin resistance in early pregnancy. When combining the effects of an ethnic origin, 0.14 kg per week (one s.d.) truncal fat gain and 4.7 kg m À 2 (one s.d.) increased pre-pregnant BMI the OR for South Asians was 5.9 (3.5-10.0) versus 2.1 (1.6-2.8) for Europeans. CONCLUSION: Weight gain and gain of total fat mass, mean skinfold thickness and especially truncal fat were all positively associated with GDM. South Asians, in particular, should be encouraged to avoid an excessive weight gain during pregnancy to reduce risk of GDM.
INTRODUCTION
Gestational diabetes mellitus (GDM) is defined as hyperglycaemia with onset or first recognition during pregnancy, 1 and is a major risk factor for later type 2 diabetes (T2DM) in the mother, 2 for several pregnancy complications, 3, 4 and probably for obesity and T2DM in the adult offspring. 5 According to the WHO Global Health Observatory, one third of the world's adults over 20 years of age were overweight or obese in 2008. 6 Consequently, a substantial number of women enter their pregnancy in an overweight or obese state, 7 and are regarded as strong risk factors for GDM. 7, 8 Not only pre-pregnancy overweight and obesity, but also an excessive gestational weight gain may lead to GDM. 9, 10 The Institute of Medicine (IOM) developed guidelines for adequate weight gain during pregnancy, 9 dependent on pre-pregnant body mass index (BMI), to reduce the risk of adverse consequences for both the mother and her offspring. 7, 11, 12 Little is known about the components of weight gain that leads to GDM, but fat mass is a likely factor as it may impose metabolic stress and constitutes a great deal of the variance of weight gain during pregnancy. 9 However, as adipose tissue may differ in its function related to its localisation, central adiposity has proven to be of importance in relation to T2DM; 13 we hypothesised that changes in total and regional deposition of fat during pregnancy, may be of importance in relation to risk of GDM.
Compared with the host populations in Europe, ethnic minority groups of non-European descent seem to be disproportionally affected by T2DM.
14 It has been suggested that the association between adiposity and T2DM is stronger in ethnic minority groups, 14 indicating a lower tolerance for adiposity. We therefore hypothesised that deposition of fat during pregnancy could contribute to ethnic differences in GDM risk especially in South Asian women, as we recently found a 2.5-fold increased risk of GDM in South Asians compared with Western Europeans in the STORK Groruddalen study. 15 The objectives of this study were to investigate the change in indicators of adiposity (being weight gain and gain of total fat, truncal fat and mean skinfold thickness) from early pregnancy to 28 weeks of gestation overall and across ethnic groups, and to explore the association between the change in indicators of adiposity and GDM defined by the modified International Association of Diabetes in Pregnancy Study Group (IADPSG) criteria (1-hour glucose not available). 1 
MATERIALS AND METHODS

Study design and subjects
The STORK Groruddalen study is a population-based cohort study of 823 healthy pregnant women attending three Child Health Clinics (CHC) for antenatal care in Oslo (covering three city districts), Norway, between May 2008 and May 2010. 16 The study and its methods have been described in detail elsewhere. 16 Information about the study was widely distributed in the three city districts of Oslo prior to study start. General practitioners were asked to refer pregnant women to the Child Health Clinics as early as possible. Midwives and research staff recruited the women at their first visit to the Child Health Clinics in early pregnancy. Women were eligible if they (1) lived in one of the three city districts, (2) planned to give birth at one of two study hospitals, (3) were less than 20 weeks pregnant at inclusion, (4) could communicate in Norwegian or any of the eight translated languages and (5) were able to give a written consent to participate. Exclusion criteria were known diabetes or the need of an intensive hospital follow-up due to other diseases. The women were included at visit 1 (V1) in gestational week o20 (Mean ¼ 15, standard deviation (s.d.) ¼ 3). Visit 2 (V2) was performed at 28±2 weeks of gestation. The study was approved by the Regional Ethics Committee and the Norwegian Data Inspectorate.
Questionnaire data
Maternal age, parity, self-reported body weight prior to pregnancy and ethnic origin were collected through interviewer-administered questionnaires at V1. Ethnicity was defined as country of birth, or participants mother's country of birth if the participants mother was born outside of Europe or North America (6.2%, n ¼ 45).
Anthropometric variables
Stature was measured twice to the nearest 0.1 cm using a fixed stadiometer (calibrated before study start and biannually) at V1. Pre-pregnant BMI was calculated using the mean value of measured height at V1 and self-reported body weight prior to pregnancy. Body weight, estimated body fat and truncal fat (that include both subcutaneous and intra-abdominal fat) were measured with a bioelectrical impedance analysis (BIA) scale (Tanita-BC 418 MA, Tanita Corporation, Tokyo, Japan) at V1 and V2 with light clothing and without shoes. The women were told to meet fasting, with an empty bladder according to the protocol. The use of Tanita-BC 418 MA has been validated in humans 17 and is not thought to cause systematic bias when estimating fat mass in pregnancy. 18 Skinfolds were measured to the nearest 1 mm with a caliper (Holtain T/W Skinfold Caliper, Holtain, Crymych, UK) at V1 and V2. The skinfolds were measured twice at triceps, subscapular and suprailiac sites. The mean skinfold was defined by the mean of all three skinfold sites and used in later analyses. Inter-rater variability, expressed as % Technical Error of Measurement (%TEM), 19 was assessed biannually. Inter-rater variability ranged from 5 to 21% between study personnel in maternal skinfolds. Intra-rater variability was less than 5% for all the measurements. 20 The maximum skinfold thickness the caliper could measure was 40 mm, before the caliper needle turned around. The highest skinfold thickness measured was therefore set as 40 mm even though it was exceeded by a few of the women (for triceps: n ¼ 11, subscapular n ¼ 4, suprailiac n ¼ 22).
Institute of Medicine's recommended range of weight gain per week in second and third trimester according to pre-pregnant BMI 9 were used to classify the proportion of women who had an inadequate, adequate or excessive weight gain from V1 to V2.
Variables of weight gain and gain of total fat, truncal fat and mean skinfold were computed by subtracting values measured at V1 from those measured at V2. Gain per week was calculated by dividing the respective gain by the number of weeks between V1 and V2 in the actual investigations.
Gestational diabetes
A 75 g oral glucose tolerance test (OGTT) was performed at V2 with fasting and 2-h plasma glucose analysed on site in the venous EDTA blood samples (HemoCue, Angelholm, Sweden). GDM was defined by a slight modification of the International Association of Diabetes in Pregnancy Study Group criteria (Fasting glucoseX5.1 mmol l À 1 or 2-h glucoseX8.5 mmol l À 1 ) as 1-h glucose was not available. 15 Insulin resistance (HOMA-IR) was calculated using the Oxford University HOMA calculator 2.2 with fasting glucose and c-peptide levels (method described in detail elsewhere). 21 Statistical analysis ANOVA with Bonferroni correction was performed to analyse the gain of body weight, fat, truncal fat and mean skinfold per week from V1 to V2 across ethnic origin. Gain of body weight, total fat, truncal fat and mean skinfold were standardized by using z-scores to ease comparison across the separate gains. Binary logistic regression analyses were performed separately for each of the gains to explore the effect of the main exposure variables (weight gain, fat gain, truncal fat gain and mean skinfold gain) on GDM (dependent variable). Univariate logistic regression analyses of each main exposure variable were performed (Model 0). In model 1 of the logistic regression we adjusted for ethnic origin, as well as the gestational week at inclusion, because the gestational week at inclusion differed somewhat across ethnic groups, and age and parity as they both could be associated with both gestational weight gain 9 and GDM. 22 In model 2, we additionally adjusted for pre-pregnant BMI, as gestational weight gain is associated with both pre-pregnant BMI and GDM. 9 We also performed separate analyses using BMI as a categorical variable and separate analyses exploring possible interactions between the BMI categories and ethnic origin. In model 3 we included HOMA-IR. All statistical analyses were performed using the IBM SPSS Statistics 19 (Chicago, IL, USA). In addition, to assess the combined effect of ethnic origin, truncal fat gain and pre-pregnant BMI we used the lincom command in StataIC version 12 (StataCorp LP, College Station, TX, USA), based on model 2 for truncal fat gain.
RESULTS
Of the total sample of 823 women, 772 met at V2 (93.8% attendance) and 759 of these underwent an oral glucose tolerance test. Seven women were excluded from analyses because of missing values at V2 (no data to compare with). Thirteen women lacked one or more observations from the bioelectrical impedance analysis scale. One woman was excluded from analyses because of imputation of the wrong height ( À 10 cm) into the bioelectrical impedance analysis scale. Additionally ten women from South and Central America were excluded due to low number and heterogeneity of ancestral origin, leaving 728 women as the study sample (94.6% of those who attended V2 and 88.7% of total sample). There were no significant differences across the baseline characteristics between the sample and the excluded women. Additionally, pre-pregnant BMI was missing for nine women who did not report their pre-pregnant body weight, leaving 719 women in model 2 and 3 of the logistic regression analysis.
The European group (n ¼ 348) consisted of ethnic Norwegians (83.0%), Eastern Europeans (11.5%), with the remaining women (5.5%) from Scandinavia, Western Europe and the USA. The South Asian group (n ¼ 181) consisted mainly of women from Pakistan (63.3%) and Sri-Lanka (30.3%). Middle East (n ¼ 110) consisted mainly of women from Iraq (30.4%), Turkey (23.5%) and Morocco (19.1%). South and Central Africa (n ¼ 50) consisted mainly of Somalis (60.0%). East Asia (n ¼ 39) consisted mainly of women from Vietnam (42.5%) and the Philippines (30.0%). Table 1 shows the baseline characteristics of the sample stratified by ethnic origin. The mean age was 29.4 years, the mean body mass index (BMI) at V1 was 25.2 kg m À 2 and the mean pre-pregnant BMI was 24.5 kg m À 2 . The mean total body fat per cent was 33.3%. There was a strong correlation between the prepregnant body weight and the measured body weight at V1 (r ¼ 0.97; regression line: body weight at V1 ¼ 3.661 þ 0.975 * pre-pregnant body weight), with no significant differences between weight gain from pre-pregnancy to V1 across ethnic groups.
Women from the Middle East had a higher BMI, both prepregnant and at V1, while East Asians had a lower pre-pregnant BMI and BMI at V1 compared to Europeans. Women from South and Central Africa had a significantly higher body fat per cent and truncal fat per cent compared to Europeans, whereas East Asian women had significantly lower values of all fat indicators estimated by the Tanita body composition analyser (Table 1) . Women from South and Central Africa had higher mean skinfold and triceps skinfold, while women from South Asia, the Middle East and South and Central Africa had higher subscapular skinfolds compared to Europeans.
In the total sample, the mean weight gain per week from V1 to V2 was 0.51 kg ( Table 2 ). The mean gain of fat mass was 0.38 kg per week, whereas 0.22 kg per week was acquired in the trunk region. The highest increases in skinfold thickness were observed in the suprailiac and subscapular site. Women from South and Central Africa had a significantly lower gain of total fat mass and truncal fat. East Asians had a significantly higher gain of mean subscapular and suprailiac skin fold, while women from South and Central Africa had a lower gain of triceps skinfold compared to Europeans. According to the Institute of Medicine guidelines, the proportion of women in our sample with an inadequate weight gain in the second trimester of pregnancy was 16.1% (n ¼ 116), adequate weight gain 22.3% (n ¼ 160) and excessive weight gain 61.6% (n ¼ 443), with no significant differences across ethnic origin.
The prevalence of GDM in the total sample was 31.5% (n ¼ 229) as defined by the modified International Association of Diabetes in Pregnancy Study Group criteria. The prevalence varied across ethnic groups, from 24.1% (n ¼ 84) in Europeans, 25.6% (n ¼ 10) in East Asians, 37.3% (n ¼ 41) in Middle Easterners, 38% (n ¼ 19) in women from South and Central Africa and 41.4% (n ¼ 75) in South Asians.
We then explored the relationship between the development of GDM and the observed gain of body weight, total fat, truncal fat and mean skinfold ( Table 3) . None of the changes in indicators of adiposity were significantly associated with risk of GDM in the univariate analysis (Model 0) or when adjusting for ethnic origin, gestational week at inclusion, age and parity (Model 1). However, when taking into account the pre-pregnant BMI, an increase in all indicators of adiposity was significantly associated with the development of GDM, with the strongest odds ratios (OR) for truncal fat gain (Model 2). A 0.14 kg per week (one s.d.) increase in the truncal fat gain gave an OR of 1.31 (95% CI 1.10-1.56) for developing GDM, while a weight gain of 0.21 kg per week gave an OR of 1.23 (95% CI 1.04-1.46). Adjusting for pre-pregnant BMI while using categories, instead of BMI as a continuous variable, did not change the ORs of the indicators of adiposity. There were no significant interactions between Asian origin and pre-pregnant BMI categories related to GDM. 
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In the final model (Model 3), that also took HOMA-IR into account, the ORs for weight gain and gain of total fat and truncal fat increased slightly, while pre-pregnant BMI was no longer significant.
Ethnic differences in weight gain and gain of total fat, truncal fat or mean skinfold did not fully explain the ethnic differences in risk of GDM, as the ORs remained high for South Asians and women from the Middle East and South and Central Africa, compared with Europeans. When adjusting for pre-pregnant BMI (Model 2) South Asians had a 2.78 higher odds of developing GDM compared with Europeans, while women from South and Central Africa had a 2.17 higher odds for developing GDM compared with Europeans. When additionally adjusting for HOMA-IR (Model 3) the OR for GDM in South Asians decreased, the OR for GDM in South and Central Africans increased and the OR for GDM in women from the Middle East was unchanged.
We used the results obtained in Model 2 for truncal fat gain to illustrate the combined effect of ethnic origin, truncal fat gain and pre-pregnant BMI on the onset of GDM, as pre-pregnant BMI is a risk factor that is more likely to be recognised in clinical antenatal care compared with insulin resistance. Figure 1 illustrates the OR for GDM for Europeans and South Asians when adding the separate effects of truncal fat gain and prepregnant BMI, and the combined effects of ethnic origin, truncal fat gain and pre-pregnant BMI. For Europeans, the single effect of ethnic origin on GDM was set as an OR of 1 (reference) and the combined effect of ethnic origin, 0.14 kg per week (one s.d.) truncal fat gain and 4.7 kg m À 2 (one s.d.) higher pre-pregnant BMI gave an OR of 2.13 (95% CI 1.62-2.80), as compared to not gaining truncal fat and not having higher pre-pregnant BMI. For South Asians, the single effect of ethnic origin gave an OR of 2.78, while the combined effect gave an OR of 5.92 (95% CI 3.51-9.98) (as compared to not gaining 0.14 kg per week truncal fat, not having 4.7 kg m À 2 higher pre-pregnant BMI and not being South Asian).
DISCUSSION
In this prospective, population-based study of a multi-ethnic population of pregnant women in Norway, gain of truncal fat Gestational gain of fat and gestational diabetes C Sommer et al during gestational weeks 14-28 had the largest effect on development of GDM among the indicators of adiposity. The effect of ethnic origin places especially South Asians at a significantly higher risk of GDM when considering the same gain of truncal fat during pregnancy and the same pre-pregnant BMI as Europeans. To our knowledge, this is the first study to explore the gain of total and regional fat during pregnancy and the association with GDM in a multi-ethnic population. Among the indicators of adiposity, gain of truncal fat mass turned out as the most potent predictor of GDM. Little is known about the relative importance of overall versus central adiposity for the risk of GDM. Some studies, suggest that central adiposity in early pregnancy may predict risk of GDM in later pregnancy. [23] [24] [25] Our finding is also supported by the well-known association found between visceral adiposity and T2DM. 13 The combined effects of ethnic origin, truncal fat gain and pre-pregnant BMI place South Asians at a particularly high-risk for developing GDM compared to Europeans. As South Asians had 2.78 times higher risk of GDM as compared to Europeans in model 2 (Table 3 ), the relative difference between the single effect of ethnic origin and the combined effect (of ethnic origin, gain of truncal fat and pre-pregnant BMI) becomes larger for South Asians (Europeans: 2.13-1 ¼ 1.13, South Asians: 5.92-2.78 ¼ 3.14). As the pre-pregnant BMI and gain of truncal fat during pregnancy of South Asians is similar to Europeans, but result in higher odds for developing GDM, South Asians are more likely diagnosed with GDM. The 'Adipose tissue compartment hypothesis' suggests that South Asians tend to store less fat in their limbs and more fat in metabolically active tissues. 26, 27 If so, South Asians may gain more fat in the truncal region, leaving them with an even higher risk of GDM.
The ORs for GDM in South Asians decreased when we additionally adjusted for HOMA-IR, supported by the widespread observation that South Asians are generally more insulin resistant. 26 For women from South and Central Africa the opposite phenomenon was observed as the ORs increased after an additional adjustment for HOMA-IR. However, the effect of the indicators of adiposity were unchanged or even increased when adjusting for HOMA-IR, suggesting that weight gain and gain of total and regional fat seem to be independent risk factors for developing GDM. However, the clinical trials to prevent excessive gestational weight gain are few, heterogeneous and are often not randomized controlled trials, 28 with the same being true for clinical trials on the prevention of GDM. 29, 30 In addition, the mean weight gain of 0.51 kg per week in the sample was high, considering the pre-pregnant BMI (24.5 kg m , 9 and women in the higher range of normal weight are advised to gain in the lower range of these recommendations. Our finding, that 61.6% of the women gained excessively is in accordance with the findings reported from a multiethnic population in the USA where 62.3% gained excessively, 31 and suggests an important arena in antenatal care for prevention-to improve maternal and offspring health.
A major strength of this study is the inclusion of ethnic minorities and immigrants, who are often excluded due to methodological considerations. The participation rate was high and the sample is considered representative for the main ethnic groups of pregnant women attending Child Health Clinics in Oslo. 16 The sample size is relatively large and the drop-out rate low. Another important strength is the prospective nature of the study and that the weight gain and gain of total and regional fat during pregnancy were measured and not self-reported. The prevalence of GDM was based on a universal screening of our population-based sample.
The pre-pregnant BMI was calculated from self-reported prepregnant body weight. We cannot rule out the possibility of biased reporting, influenced by either weight or ethnicity, but the strong correlation between self-reported pre-pregnant body weight and the measured body weight at V1 is reassuring. In addition, the similar weight gain from pre-pregnancy to V1 across ethnic groups is indicative of an absence of systematic bias.
Studies have suggested that the use of BMI in Asians underestimate their adiposity, as they have a lower BMI relative to their actual fat mass 32, 33 and have a higher prevalence of diabetes at a lower BMI. 34 As pre-pregnant BMI was adjusted for in the logistic regression, this could be one of probably several reasons, why a South Asian origin still constitutes a higher risk of GDM.
Despite some concerns of interpreting the results of bioelectrical impedance analysis in pregnancy, we observed that the parameters estimated by the Tanita scale followed the same trends as the measurements of skinfolds, indicating that the Tanita actually captured real differences. Potential bias is usually reduced when each subject is its own control. In addition, our finding that the highest increases in skinfold thickness were observed in the suprailiac and subscapular site supports the observed relatively high gain of truncal fat mass, as subscapular and suprailiac skinfolds are considered surrogate measures of visceral fat. The Tanita estimates for truncal fat also predicted GDM more effectively than did weight gain and mean skinfold.
To conclude, gains of total weight, total fat, mean skinfold and particularly truncal fat increased the risk of GDM in this multiethnic population of women. South Asians had a higher OR for the same gain of truncal fat and the same pre-pregnant BMI compared to Europeans, even though they had the same gain of truncal fat and the same pre-pregnant BMI as Europeans. Intervention studies to reduce pre-pregnant BMI and limit fat gain during pregnancy, should be undertaken to test if such can reduce the risk of GDM and its consequences for mother and offspring.
